<?xml version="1.0" encoding="UTF-8"?>
<p>Despite the opportunity to lower drug prices, many low-income countries tend to shy away from using compulsory licenses for pharmaceutical products. Admittedly, some countries are bound by restrictions in bilateral relations such as free-trade agreements with provisions limiting the use of compulsory licenses. However, many countries are not legally restricted from compulsory licensing but avoid doing so due to fears of trade retaliation and the complicated nature of imposing compulsory licenses [
 <xref rid="R9" ref-type="bibr">9</xref>]. Such barriers are difficult but not insurmountable.
</p>
